Clarus Therapeutics Holdings Inc (CRXT)

Not featured in screeners

Not featured in screeners

Ticker: CRXT

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

THOMAS MCNERNEY & PARTNERS LP

6 sales — total 9,494,867 USD

Sale 20 Apr 2022

Value US$3,575,268.50 | Price 92.69 | Shares 25,943

Sale 20 Apr 2022

Value US$3,732,539.93 | Price 406.69 | Shares 99,775

Sale 20 Apr 2022

Value US$34,483.90 | Price 2.53 | Shares 13,630

Sale 20 Apr 2022

Value US$14,476.66 | Price 2.53 | Shares 5,722

Sale 20 Apr 2022

Value US$5,216,063.05 | Price 2.53 | Shares 2,061,685

Sale 20 Apr 2022

Value US$4,207,708.78 | Price 2.53 | Shares 1,663,126

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2022-04-21	2022-04-20	S Sale	3.4 THOMAS MCNERNEY & PARTNERS LP Large shareholder	25,943 -14.4% 92.69 US$3,575,268	25,943 -14.4%	92.69	US$3,575,268
2022-04-21	2022-04-20	S Sale	3.4 THOMAS MCNERNEY & PARTNERS LP Large shareholder	99,775 -25.7% 406.69 US$3,732,540	99,775 -25.7%	406.69	US$3,732,540
2022-04-21	2022-04-20	S Sale	3.4 THOMAS MCNERNEY & PARTNERS LP Large shareholder	89,526 +8.6% 267.16 US$3,376,423	89,526 +8.6%	267.16	US$3,376,423
2022-04-21	2022-04-20	S Sale	3.4 THOMAS MCNERNEY & PARTNERS LP Large shareholder	5,722 -68.3% 2.53 US$14,477	5,722 -68.3%	2.53	US$14,477
2022-04-21	2022-04-20	S Sale	3.4 THOMAS MCNERNEY & PARTNERS LP Large shareholder	2,061,685 -68.3% 2.53 US$5,216,063	2,061,685 -68.3%	2.53	US$5,216,063
2022-04-21	2022-04-20	S Sale	3.4 THOMAS MCNERNEY & PARTNERS LP Large shareholder	1,663,126 -68.3% 2.53 US$4,207,709	1,663,126 -68.3%	2.53	US$4,207,709

More insider trading research around Clarus Therapeutics Holdings Inc